Dr Dominik Rückerl

Location: Room 304, Ashworth Laboratories

Phone: 0131 650 7317

Email: dominik.ruckerl@ed.ac.uk

Website: http://www.nematodes.org/allenlab/people/ruckerl.htm

CV

Publications

 
Zeisig R, Rückerl D, Fichtner I.
Reduction of tamoxifen resistance in human breast carcinomas by tomoxifen-containing liposomes in vivo. Anticancer Drugs . 2004 Aug;15(7):707-14.
Holscher C, Holscher A, Rückerl D, Yoshimoto T, Yoshida H, Mak T, Saris C, Ehlers S.
The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol. 2005 Mar 15;174(6):3534-44.
Rückerl D, Hessmann M, Yoshimoto T, Ehlers S, Holscher C..
Alternatively activated macrophages express the IL-27 receptor alpha chain WSX-1. Immunobiology. 2006 Jul;211(6-8):427-36.
Hopner S, Dickhaut K, Hofstatter M, Kramer H, Rückerl D, Soderhall JA, Gupta S, Marin-Esteban V, Kuhne R, Freund C, Jung G, Falk K, Rotzschke O.
Small organic compounds enhance antigen loading of class II major histocompatibility comples proteins by targeting the polymorphic P1 pocket.. J Biol Chem. 2006 Dec 15;281(50):38535-42.
Nigg AP, Zahn S, Rückerl D, Holscher C, Yoshimoto T, Ehrchen JM, Wolbing F, Udey MC, von Stebut E.
Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice. J. Immunol 2007 Jun 1;178(11):7251-8.